James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 243,320 shares at $13.26 ($3.1M) on 2016-06-01, disclosed to the SEC on 2016-06-01.
Open-market purchase of $3.1M RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.43 | 56,739 | $649K | 21.0% |
| 2 | $12.76 | 127,691 | $1.6M | 52.8% |
| 3 | $13.26 | 28,797 | $382K | 12.4% |
| 4 | $14.11 | 23,890 | $337K | 10.9% |
| 5 | $14.22 | 6,203 | $88K | 2.9% |
| Total | $12.68 avg | 243,320 |
| $3.1M |
| 100% |
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |